Health Care • Medical/Nursing Services
$4.20 ▲ +0.17
(+4.22%)
MKT CAP: $30.5M • VOL: 49.9K
52W L $2 52W H $17
PIII // SEC EDGAR XBRL STANDARDIZED FINANCIAL STATEMENTS (FA <GO>)
| LINE ITEM (USD / %) | FY 2025
FILED 2025-12-31 | FY 2024
FILED 2024-12-31 | FY 2023
FILED 2023-12-31 |
|---|---|---|---|
| Revenue (Total Sales) | $1.46B | $1.50B | $1.27B |
| YoY Revenue Growth % | -2.8% | +18.5% | — |
| Gross Profit | — | — | — |
| Gross Margin % | — | — | — |
| Research & Development (R&D) | — | — | — |
| Operating Income (EBIT) | -$270.3M | -$320.7M | -$167.9M |
| Operating Margin % | -18.5% | -21.4% | -13.3% |
| Net Income (GAAP) | -$147.9M | -$135.8M | -$57.8M |
| EBITDA (Normalized) | — | -$320.7M | — |
| Diluted EPS ($/sh) | — | — | — |
| Operating Cash Flow (OCF) | -$91.2M | -$110.1M | -$76.0M |
| Capital Expenditures (CapEx) | — | $0 | — |
| Free Cash Flow (FCF) | -$91.2M | -$110.1M | -$76.0M |
| FCF Margin % | -6.3% | -7.3% | -6.0% |
| Return on Invested Capital (ROIC %) | -45.0% | -45.0% | — |
| Cash & Short-Term Equivalents | $25.0M | $38.8M | — |
| Total Debt (Short + Long Term) | $228.4M | $108.9M | — |
| Total Stockholders' Equity | -$155.2M | $75.9M | — |
NO QUARTERLY 10-Q XBRL STATEMENTS AVAILABLE IN CURRENT CACHE FOR PIII.